2016 AIChE Annual Meeting

Area: Pharmaceuticals

Chair

Jacob Albrecht, Bristol-Myers Squibb Co.

Sessions co-sponsored

Advances in Bioreactions and Bioprocessing (Invited Talks)
Sponsored by:
Co-sponsored by:
Amorphous Solid Dispersions for Drug Product
Sponsored by:
Co-sponsored by:
Continuous Processing in the Manufacture of Pharmaceuticals: Drug Product I
Sponsored by:
Co-sponsored by:
Continuous Processing in the Manufacture of Pharmaceuticals: Drug Product II
Sponsored by:
Co-sponsored by:
Continuous Processing in the Manufacture of Pharmaceuticals: Drug Substance (In memory of Tom LaPorte)
Sponsored by:
Co-sponsored by:
Critical Quality Attribute Monitoring and Control in Drug Substance Manufacturing I
Sponsored by:
Co-sponsored by:
Critical Quality Attribute Monitoring and Control in Drug Substance Manufacturing II
Sponsored by:
Co-sponsored by:
Forum Plenary: Pharmaceutical Discovery, Development, and Manufacturing Forum
Sponsored by:
Co-sponsored by:
Innovations at the Product Design and Discovery Interface
Sponsored by:
Co-sponsored by:
Innovations in Biopharmaceutical Discovery, Development, and Manufacturing I
Sponsored by:
Co-sponsored by:
Innovations in Biopharmaceutical Discovery, Development, and Manufacturing II
Sponsored by:
Co-sponsored by:
Innovations in Drug Delivery Technology
Sponsored by:
Co-sponsored by:
Materials and Process Development for Hybrid Therapeutics
Sponsored by:
Co-sponsored by:
Materials Science in Pharmaceutical Process Development I
Sponsored by:
Co-sponsored by:
Materials Science in Pharmaceutical Process Development II
Sponsored by:
Co-sponsored by:
Model Based Integrated Design of Pharmaceutical Drug Product Processes
Sponsored by:
Co-sponsored by:
Model Based Integrated Design of Pharmaceutical Drug Substance Processes
Sponsored by:
Co-sponsored by:
Panel: Challenges for the Pharmaceutical Industry (Invited Talks)
Sponsored by:
Co-sponsored by:
Particle Engineering As Applied to Pharmaceutical Formulations II
Sponsored by:
Co-sponsored by:
PAT for Process Understanding, Reduced Testing, and Elucidation of Fundamental Phenomena in Drug Product/Substance Development
Sponsored by:
Co-sponsored by:
Poster Session: Pharmaceutical
Sponsored by:
Co-sponsored by:
Predictive Scale-Up/Scale-Down for Production of Pharmaceuticals and Biopharmaceuticals
Sponsored by:
Co-sponsored by:
Product Quality Attribute Monitoring and Control in Drug Product Manufacturing
Sponsored by:
Co-sponsored by:
Quality By Design in Drug Product Formulation, Design, & Process Development I
Sponsored by:
Co-sponsored by:
Quality By Design in Drug Product Formulation, Design, & Process Development II
Sponsored by:
Co-sponsored by:
Quality By Design in Drug Substance Process Development
Sponsored by:
Co-sponsored by:
Tools for Accelerating Pharma Development and Innovations in Biopharmaceutical Discovery, Development, and Manufacturing
Sponsored by:
Co-sponsored by: